The 2020s was the era when the full commercial promise of cell, gene and RNA therapies was to be realized – this was only accelerated by the pandemic. Collectively known as advanced therapies, they have the potential to treat numerous diseases. We now are at a pivotal moment; which will see enormous changes to usher cell, gene, and RNA therapies into the pharmacotherapeutic mainstream.
June 07, 2022 | 10:00 AM GMT+01:00
